Fundraising Fox

Amplifi Vascular

Prairie Village, US · Founded 2023 · Delaware corporation

Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump with inflow and outflow catheters that uses proprietary hemodynamic technology to enlarge veins before arteriovenous fistula (AVF) creation. The device is intended to increase patient eligibility for AVF surgery and improve vascular access outcomes for hemodialysis patients.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

SM
Sean MorrisExecutive

Board

NH
Nathaniel HagedornBoard director
JS
James SchultzBoard director
SB
Steve BraunBoard director

Reported raises · per SEC filings

Form D private placements

$6.8M disclosed across 2 rounds · 2023–2024

▶$6MraisedJun 2026 · 59 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathaniel HagedornDirector
  • James SchultzDirector
  • Steve BraunDirector
  • Sean MorrisExecutive Officer, Director
Offering amount
$12M
Amount sold
$6M
First sale
Aug 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$808KraisedJun 2024 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean MorrisExecutive Officer, Director
  • Steve BraunDirector
  • Nathaniel HagedornDirector
  • James SchultzDirector
Offering amount
$8M
Amount sold
$808K
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Amplifi Vascular Closes $6.8M in Series A Fundingfinsmes.com · Oct 2025Amplifi Vascular: $6.9 Million Series A Closed For Vein Dilation Systempulse2.com · Oct 2025Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval - BioSpacebiospace.com · Oct 2025Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approvalprnewswire.com · Oct 2025

Frequently asked questions

What does Amplifi Vascular do?
Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump with inflow and outflow catheters that uses proprietary hemodynamic technology to enlarge veins before arteriovenous fistula (AVF) creation. The device is intended to increase patient eligibility for AVF surgery and improve vascular access outcomes for hemodialysis patients.
How much funding has Amplifi Vascular raised?
Amplifi Vascular has disclosed $6.8M raised across 2 rounds.
Where is Amplifi Vascular headquartered?
Amplifi Vascular is headquartered in Prairie Village, US.